Literature DB >> 1994941

Cerebral circulation and metabolism in patients with septic encephalopathy.

T Maekawa1, Y Fujii, D Sadamitsu, K Yokota, Y Soejima, T Ishikawa, Y Miyauchi, H Takeshita.   

Abstract

Cerebral circulation and metabolism in septic encephalopathy have not been well documented. The authors measured cerebral blood flow (CBF) and metabolic rate for oxygen (CMRO2) in six patients with septic encephalopathy associated with multiple organ failure (three to five organs). They found that CBF and CMRO2 were significantly lower than awake control values of 46 +/- 2 to 28 +/- 3 mL/100g/min (mean +/- SEM) and 3.1 +/- 0.2 to 1.2 +/- 0.2 mL/100g/min, respectively. Cerebral vascular resistance (CVR) and cerebral circulatory index (CCI:CBF/CMRO2) were significantly higher than the control values of 2.0 +/- 0.1 to 3.0 +/- 0.4 mm Hg/mL/100g/min and 15.1 +/- 0.8 to 24.2 +/- 3.3, respectively. At the time of cerebral circulatory and metabolic measurements, their consciousness varied between 4 and 10 as evaluated by the Glasgow coma scale. The electroencephalogram showed diffuse slow wave activity and the latency of the auditory brain stem evoked response was prolonged in four of six patients. Computed brain tomography showed either no abnormality or mild atrophy. It is concluded that CBF and CMRO2 are disproportionally decreased during septic encephalopathy in association with dysfunction of the CNS and decreased electrical activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1994941     DOI: 10.1016/0735-6757(91)90175-j

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  17 in total

Review 1.  Neuro-oxidative-nitrosative stress in sepsis.

Authors:  Ronan M G Berg; Kirsten Møller; Damian M Bailey
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-13       Impact factor: 6.200

2.  Cerebral blood flow velocity in early-onset neonatal sepsis and its clinical significance.

Authors:  Sriparna Basu; Shashikant Dewangan; Ram Chandra Shukla; Shampa Anupurva; Ashok Kumar
Journal:  Eur J Pediatr       Date:  2012-01-04       Impact factor: 3.183

Review 3.  [Septic encephalopathy].

Authors:  C Terborg
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-06       Impact factor: 0.840

Review 4.  Blood-brain barrier breakdown in septic encephalopathy and brain tumours.

Authors:  D C Davies
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

5.  Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice.

Authors:  Tsuyoshi Nishioku; Shinya Dohgu; Fuyuko Takata; Tomoaki Eto; Naoko Ishikawa; Kota B Kodama; Shinsuke Nakagawa; Atsushi Yamauchi; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2008-11-06       Impact factor: 5.046

Review 6.  Cerebral perfusion in sepsis.

Authors:  Christoph S Burkhart; Martin Siegemund; Luzius A Steiner
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

7.  Impaired cerebrovascular reactivity in sepsis-associated encephalopathy studied by acetazolamide test.

Authors:  Szilárd Szatmári; Tamás Végh; Akos Csomós; Judit Hallay; István Takács; Csilla Molnár; Béla Fülesdi
Journal:  Crit Care       Date:  2010-03-31       Impact factor: 9.097

Review 8.  Oxidative mechanisms of brain dysfunction during sepsis.

Authors:  Felipe Dal-Pizzol; Cristiane Ritter; Omar J Cassol; Gislaine T Rezin; Fabrícia Petronilho; Alexandra I Zugno; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2009-08-14       Impact factor: 3.996

9.  Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock.

Authors:  Fabio Silvio Taccone; Diego Castanares-Zapatero; Daliana Peres-Bota; Jean-Louis Vincent; Jacques Berre'; Christian Melot
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

Review 10.  Bench-to-bedside review: critical illness-associated cognitive dysfunction--mechanisms, markers, and emerging therapeutics.

Authors:  Eric B Milbrandt; Derek C Angus
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.